VIRGINIA RETIREMENT SYSTEMS ET AL - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2021. The put-call ratio across all filers is 8.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
VIRGINIA RETIREMENT SYSTEMS ET AL ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$509,795
+2.3%
14,300
+32.4%
0.01%0.0%
Q2 2023$498,204
+25.5%
10,800
+9.1%
0.01%
+25.0%
Q1 2023$396,990
+53.0%
9,900
+76.8%
0.00%
+33.3%
Q4 2022$259,448
+2.7%
5,600
-8.2%
0.00%0.0%
Q3 2022$252,601
-66.9%
6,100
-41.9%
0.00%
-57.1%
Q1 2022$763,000
-34.7%
10,500
-24.5%
0.01%
-12.5%
Q4 2021$1,169,000
+5.4%
13,900
+13.0%
0.01%
-27.3%
Q3 2021$1,109,000
+14.0%
12,300
+20.6%
0.01%
+10.0%
Q2 2021$973,000
-17.8%
10,200
-1.9%
0.01%
-16.7%
Q1 2021$1,184,000
-0.5%
10,400
+20.9%
0.01%0.0%
Q4 2020$1,190,000
+281.4%
8,600
+126.3%
0.01%
+200.0%
Q3 2020$312,000
+42.5%
3,800
+35.7%
0.00%
+33.3%
Q2 2020$219,0002,8000.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2021
NameSharesValueWeighting ↓
Iguana Healthcare Management, LLC 75,000$5,084,0002.52%
COLUMBIA WANGER ASSET MANAGEMENT LLC 1,237,825$83,900,0001.18%
CAPITAL INTERNATIONAL LTD /CA/ 206,718$14,011,0000.91%
Cormorant Asset Management, LP 75,000$5,084,0000.74%
Capital International Sarl 107,450$7,283,0000.63%
Rock Springs Capital Management LP 159,750$10,828,0000.62%
Opus Point Partners Management, LLC 12,201$827,0000.61%
Hood River Capital Management LLC 109,629$7,431,0000.56%
Aureus Asset Management, LLC 50,740$2,927,0000.51%
ROCKEFELLER FINANCIAL SERVICES INC 374,663$25,395,0000.51%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders